Effect of a pharmacist managed smoking cessation clinic on quit rates

  • Ann M. Philbrick
  • Erin N. Newkirk
  • Karen B. Farris
  • Deanna L. McDanel
  • Kathleen E. Horner
Keywords: Smoking Cessation, Health Education, Pharmacists, United States


Objective: The purpose of this study was to quantify quit rates, determine factors predicting success, and analyze patients' perceptions at 3 months after participation in the pharmacist-managed Smoking Cessation Group Clinic.

Methods: This was a prospective, single group study that was conducted in patients that had participated in the Smoking Cessation Group Clinic at the University of Iowa Hospitals and Clinics. Clinic participants received structured group counseling covering various topics associated with cessation. Varenicline, bupropion and nicotine replacement therapy were used as smoking cessation aids and selection was based on patient preference and absence of contraindications. The primary outcome of this trial was smoking status at 3 months. The patients were contacted by telephone at 3, and 6 months after the start of the clinic and asked about current smoking status. At 3 months, patients were asked to rate on a Likert scale of 1 to 5 (1=not helpful; 5=very helpful) their perceptions of individual aspects of the clinic and on a scale of 1 to 10 (1=not helpful; 10=very helpful) how they perceived their cessation aid.

Results: From February 2007 to January 2008, 21 patients enrolled in the intent-to-treat follow up study. Analysis of data was completed in August 2008. At 3 and 6 months, 47.6% and 52.4%, of patients reported being smoke-free, respectively. At 3 months, factors consistent with success included having more previous quit attempts and type of cessation aid used. These endpoints continued to be significant at 6 months, in addition to attending more clinic sessions, and type of insurance (favoring private insurance). Patients who quit smoking rated their cessation aid as more helpful than those who did not quit smoking (8.56; SD=0.88 verses 6.71; SD=2.81, respectively; p=0.14). The aspect of the clinic most helpful to patients was group interaction (4.53; SD=0.77).

Conclusion: This study demonstrates that pharmacists can play a vital role with smoking cessation in a group setting. Group setting patient counseling can be an effective tool for pharmacists to reach more people within the same time frame as individual counseling.


Download data is not yet available.


1. United States Department of Health and Human Services. Health Consequences of Smoking. Executive Summary. May 27, 2004.

2. American Cancer Society. Cancer Facts and Figures 2006. http://www.cancer.org/downloads/STT/CAFF2006PWSecured.pdf (accessed on March 10, 2009).

3. United States Department of Health and Human Services. Healthy People 2010. Vol. 2. November 2000.

4. Centers for Disease Control and Prevention. Cigarette Smoking Among Adults—United States, 2007. MMWR. 2008;57(44);1221-1226.

5. Centers for Disease Control. Cigarette smoking among adults—United States, 2004. MMWR. 54(44);1121-1124.

6. Fichtenberg CM, Glantz SA. Effect of a smoke-free workplace on smoking behaviour: systematic review. BMJ. 2002:325;188-195.

7. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD, Orleans CT, Robinson L, Sitzer ML, Tommasello AC, Villejo L, and Wewers ME. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. May 2008.

8. Dent LA, Scott JG, Lewis E. Pharmacist-managed tobacco cessation program in veteran’s health administration community-based outpatient clinic. J Am Pharm Assoc. 2004;44(6):700-715.

9. Hudmon KS, Berger BA. Pharmacy applications of a transtheoretical model in smoking cessation. Am J Health-Sys Pharm. 1995;52:282-287.

10. Zillich AJ, Ryan M, Adams A, Yeager B, Farris KB. Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life. Pharmacotherapy. 2002:22(6),759-765.

11. Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009;43:194-201.

12. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12(2):159-182.

13. Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control. 1997;6:s55-s61.

14. Hertel AW, Finch EA, Kelly KM, King C, Lando H, Linde JA, Jeffrey RW, Rothman AJ. The impact of expectations and satisfaction on the initiation and maintenance of smoking cessation: an experimental test. Health Psychol. 2008;27:s197-s206.
How to Cite
Philbrick AM, Newkirk EN, Farris KB, McDanel DL, Horner KE. Effect of a pharmacist managed smoking cessation clinic on quit rates. Pharm Pract (Granada) [Internet]. 2009Sep.3 [cited 2021Sep.22];7(3):150-6. Available from: https://www.pharmacypractice.org/journal/index.php/pp/article/view/154
Original Research